Drug Repurposing Candidates for Type 1 Diabetes Mellitus Identified by Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells with Monocyte-Focused Transcriptomic Analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Provisional patent specification disclosing drug repurposing candidates for T1DM identified by scRNA-seq of PBMCs (GSE221297, n=12 donors, 60k cells). Monocyte clusters 11/12/13/16 yielded 2,749 DE genes; LINCS L1000 analysis identified Na+/K+-ATPase inhibitors (digitoxigenin, ouabain, bufalin, cinobufagin, cymarin, sarmentogenin) as top candidates with cross-disease signal for QL-XII-47.
Fields of Study & Subjects
Diabetes and associated disorders
Single-cell and spatial transcriptomics
Pancreatic function and diabetes
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN